Abstract
Late preterm antenatal corticosteroid (ACS) administration is standard of care since publication of Antenatal Betamethasone for Women at Risk for Late Preterm Delivery (ALPS) trial. Previous data suggests incomplete or nonoptimal steroid exposure is associated with decreased efficacy, but prediction of delivery timing remains a challenge. Our aim was to investigate if the obstetric indication for steroids is predictive of optimal steroid exposure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
